bibliographic entry 880428 [be/880428]
https://w3id.org/oc/corpus/be/880428

is a

• bibliographic reference

content

• Co, M. Merck Announces Data from Pivotal Phase 3 Fracture Outcomes Study for Odanacatib, an Investigational Oral, Once-Weekly Treatment for Osteoporosis, 2014, http://www.mercknewsroom.com/news-release/research-and-development-news/merck-announces-data-pivotal-phase-3-fracture-outcomes-st

references

• https://w3id.org/oc/corpus/br/1271086